Clinical Trial Update: A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)

View source ↗

Summary

This clinical trial is currently recruiting to evaluate whether IL-17 inhibitors (e.g., Secukinumab) reduce subclinical enthesitis in patients with moderate-to-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Psoriasis (PsO), Enthesitis | Status: RECRUITING